Holocene Advisors, LP Vincerx Pharma, Inc. Transaction History

Holocene Advisors, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $4.39 Million	162,681 Added 27.32%	758,214 $9.85 Million
Q1 2021 May 17, 2021	BUY	$22.6 - $31.0 $5.11 Million - $7.02 Million	226,303 Added 61.29%	595,533 $11.5 Million
Q4 2020 Feb 16, 2021	BUY	$12.85 - $19.95 $4.74 Million - $7.37 Million	369,230 New	369,230 $7.72 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $3.18M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.